The Townsend-Jeantet Prize Trust
Unaudited Trust Accounts
Year to 5th April 2021
Couch Bright King & Co 1st Floor, Shropshire House 179 Tottenham Court Road London W1T 7NZ
14/03/2022 09:59
The Townsend-Jeantet Prize Trust
Year to 5th April 2021
Trustees' Approval
We approve the unaudited Statement of Financial Affairs and confirm that we have made available all relevant records and information for their preparation.
Professor Alain Townsend FRS
Nigel Hamway Esq
Chartered Accountant's Report to the Trustees on the Unaudited Financial Statements for the Year Ended 5th April 2021
As described above, you have approved the unaudited Statement of Financial Affairs for the year ended 5th April 2021 set out on pages 1 to 3. In accordance with your instructions, we have compiled the unaudited Statement of Financial Affairs from the accounting records , information and explanations supplied to us.
Couch Bright King & Co Chartered Accountants
1st Floor, Shropshire House
179 Tottenham Court Road, London, WC1E 6AB
14 March 2022
14/03/2022 09:59
The Townsend-Jeantet Prize Trust
Trustees’ Report for the year to 5[th] April 2021
Trusts
Policies
Professor Alain Townsend founded the Charity by a Deed dated 1st June 1992.
The objects of the Trust are the promotion of medical biological and chemical research into the causes and treatment of disease and the publishing of useful results thereof. No part of the capital or income of the Trust can be paid or applied for any purpose which is not charitable.
The Trustees may also make grants, loans and other forms of financial assistance to individuals and make contributions out of capital or income towards the objects or expenses of any charity having similar objects to the Trust
The Trustees regard both realised and unrealised investment gains as an accretion to the historic capital fund rather than as income available for distribution. Correspondingly investment losses and expenditure referable to capital are a deduction from the historic capital fund.
The portfolio is invested in a UK common investment fund for charities administered by BNY Mellon Fund Managers Ltd. This aims maximise total returns through capital growth and income.
The Trustees may accumulate income as an accretion to capital if they so decide.
The Trust is registered with the Charity Commission No 1011770. Its principal office is at The Institute of Molecular Medicine, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU.
The power to appoint new Trustees is vested in the Founder during his lifetime and thereafter in the Trustees.
Trustees
Professor Alain Townsend FRS
Nigel Hamway Esq
............................................... ...........................
Professor Alain Townsend FRS., Date
14/03/2022 09:59
THE TOWNSEND-JEANTET PRIZE TRUST
Page 1
Statement of Financial Activities, Year to 5th April 2021
| Incoming Resources Incoming resources from generated funds Voluntary Income Donations Investment Income Dividends from UK Unit Trusts NatWest Bank Interest - gross Total incoming resources Resources expended Charitable Activities Charitable Payments See schedule attached Governance Costs Tax and Accountancy Fees Couch Bright King & Co Total resources expended Net incoming/outgoing resources Other recognised gains/losses Gains/losses on investment Assets Based on historic cost Accounting method adjustment Unrealised gain/(loss) on investments Net movement in funds Reconciliation of Funds Total funds brought forward Total funds carried forward |
2021 Unrestricted Total Funds 25,000.00 25,000.00 5,549.66 5,549.66 0.00 0.00 30,549.66 30,549.66 0.00 0.00 1,440.00 1,440.00 1,440.00 1,440.00 29,109.66 29,109.66 0.00 0.00 0.00 0.00 0.00 0.00 49,476.62 49,476.62 49,476.62 49,476.62 234,296.19 234,296.19 312,882.47 312,882.47 |
2020 Balance Sheet Fixed Assets 0 Investments 7,370 0 7,370 Total fixed assets Current Assets Cash at bank and in hand NatWest Bank 0 Business Reserve Account Current Account 2,331 2,331 5,039 Liabilities 0 Creditors: Amounts falling due within one year Couch Bright King & Co 695 Donations and bursaries 8,594 Net current assets or liabilities (32,237) Total assets less current liabilities (22,948) The funds of the charity Unrestricted income funds 252,205 Total unrestricted funds 234,297 Total charity funds |
2021 Unrestricted Total Funds 286,989.88 286,989.88 286,989.88 286,989.88 0.91 0.91 30,730.68 30,730.68 30,731.59 30,731.59 4,839.00 4,839.00 0.00 0.00 25,892.59 25,892.59 312,882.47 312,882.47 312,882.47 312,882.47 312,882.47 312,882.47 312,882.47 312,882.47 |
2020 231,963 |
|---|---|---|---|---|
| 231,963 | ||||
| 1 5,731 |
||||
| 5,732 | ||||
| 3,399 0 2,333 234,296 |
||||
| 234,296 234,296 234,296 |
ACS2021.xls 4
14/03/2022 09:59
THE TOWNSEND-JEANTET PRIZE TRUST
Page 2
Investments Account, year to 5th April 2021
| Holdings at 6.4.2020 Transactions during the period Nominal Market Date Nominal Cost/ Value (Proceeds) Newton Grwth & Inc Fund for Charities 188,465.7170 231,964 31.5.2020 1,041.5750 1,394.46 31.8.2020 1,152.0410 1,569.31 30.11.2020 954.2100 1,357.65 28.2.2021 855.0230 1,228.24 231,964 5,549.66 |
Holdings at 6.4.2020 Transactions during the period Nominal Market Date Nominal Cost/ Value (Proceeds) Newton Grwth & Inc Fund for Charities 188,465.7170 231,964 31.5.2020 1,041.5750 1,394.46 31.8.2020 1,152.0410 1,569.31 30.11.2020 954.2100 1,357.65 28.2.2021 855.0230 1,228.24 231,964 5,549.66 |
Holdings at 5.4.2021 Gain/ Nominal Adjusted Market (Loss) Value Value 192,468.5660 237,513.26 286,990 0.00 237,513.26 286,990 |
Dividends/ Interest 5,549.66 |
|---|---|---|---|
| 5,549.66 | 5,549.66 |
ACS2021.xls 5
14/03/2022 09:59